Today: 2 May 2026
Chevron stock price near $181 as oil risk returns: what CVX investors watch next week
7 February 2026
1 min read

Chevron stock price near $181 as oil risk returns: what CVX investors watch next week

New York, Feb 7, 2026, 13:58 (EST) — Market closed

  • Chevron finished Friday’s session 0.9% higher at $180.86, right around its 52-week peak.
  • Oil prices finished up, with traders sizing up the possibility of fresh tensions between the U.S. and Iran.
  • One Chevron executive exercised options and sold the shares on the same day, according to a Form 4 filing.

Chevron finished Friday at $180.86, up 0.91%. Shares moved between $179.51 and $182.10 during the session. After the bell, the stock ticked slightly higher to $180.94.

U.S. markets are closed for the weekend, leaving Monday’s outlook leaning on macro factors and oil prices. Chevron shares have hovered near their highs; a single headline or a sudden swing in crude could flip sentiment fast.

Friday saw a sharp bounce across U.S. stocks. The S&P 500 jumped 1.97%, the Dow climbed 2.47%. Shares of Exxon Mobil and ConocoPhillips moved higher, too.

Oil ended the day up on Friday, shrugging off earlier declines as jitters lingered around U.S.-Iran negotiations and the potential for conflict. Brent closed at $68.05 a barrel, while U.S. WTI wrapped up at $63.55. “It’s status quo nervousness over Iran,” said John Kilduff, partner at Again Capital. Reuters

Chevron’s caught between the swings. When crude prices rise, upstream cash flow gets a boost. But on the refining and chemicals side, margin shifts and plant outages can drag the other direction—so the stock tends to move in fits and starts.

Chevron executive Andrew Benjamin Walz, who heads the company’s downstream, midstream and chemicals segment, exercised options on 22,200 shares and immediately sold the same amount at a weighted-average price of $176.5338, according to a Form 4. The Feb. 3 sales ranged from $176.44 to $176.65 across multiple trades. After the transactions, Walz holds 666 shares directly.

Monday’s focus shifts to whether energy keeps pulling in cash while some investors step away from tech. “Rotation is the dominant theme this year,” said Angelo Kourkafas, senior global investment strategist at Edward Jones, noting recent momentum in “old-economy sectors.” Reuters

But that support doesn’t always last. Should the Middle East risk premium—basically, the additional cost traders tack on when they’re worried about supply getting hit—start to unwind, crude prices could retreat. Integrated majors would likely follow.

Traders eye oil to see if Friday’s gains stick when futures start up again. Another thing: the next batch of U.S. data could shake up rate and dollar bets—potentially moving the goalposts for energy demand and pricing, which hits companies like Chevron directly.

Looking ahead, investors will get January’s Employment Situation numbers first, out Wednesday, Feb. 11 at 8:30 a.m. ET. Then comes the January CPI on Friday, Feb. 13, also at 8:30 a.m. ET. Both reports pack the kind of punch that tends to jolt oil-sensitive shares as the week wraps.

Stock Market Today

  • Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan
    May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could pressure margins. Forecasts project ¥1.38 trillion revenue and ¥517 billion earnings by 2028, implying modest growth. Analysts remain divided, with some optimistic on AI-driven pipeline advancements, while others caution on pricing and competitive threats. The governance changes highlight an evolving incentive model as Chugai navigates opportunities and challenges in biologics and Roche partnership dynamics.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 02.05.2026

2 May 2026
LIVEMarkets rolling coverageStarted: May 2, 2026, 12:00 AM EDTUpdated: May 2, 2026, 1:43 AM EDT Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could
US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026
Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.
McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026
McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.
Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade
Previous Story

Healthcare stocks in focus: Molina shock, FDA “copycat” warning and XLV set up Monday’s trade

LVMH stock price: what to watch after Friday’s close and ahead of Monday trade
Next Story

LVMH stock price: what to watch after Friday’s close and ahead of Monday trade

Go toTop